Join us at JPM26 in SF + online Jan 12-13
No images? Click here
Beyond the JPM pitch
JANUARY 12 - 13, 2026 | 7:00 AM - 5:00 PM PT
MARRIOTT MARQUIS, SAN FRANCISCO
Biopharma is operating without a map. The funding landscape has shifted, regulatory rules keep changing, China’s role is evolving, and markets remain volatile. As the industry gathers in San Francisco, one question echoes: What actually works when capital is scarce and the old playbook is dead?
Join veteran executives making Endpoints at JPM their base. The Endpoints Hub is your retreat from Union Square chaos, with private meeting spaces, serious attendees, and a place where quick chats can turn into deals.
Save 15% when you buy a group pass — you can choose your attendees later
- Virtual passes are available at no charge
NEW SPEAKERS JUST ANNOUNCED
- Mike Doustdar, President and CEO of Novo Nordisk A/S
- Reenie McCarthy, CEO of Stealth BioTherapeutics
- Robert Nelsen, Co-founder & Managing Director of ARCH Venture Partners
View the full agenda here.
Mike Doustdar
President and CEO of Novo Nordisk A/S
THE CONVERSATIONS THAT MATTER
John Carroll returns with Catalent CEO Alessandro Maselli to make their predictions for the coming year. Vir Biotechnology CEO Marianne De Backer joins for a fireside, while panels on oncology R&D and dealmaking anchor the morning sessions.
This isn’t just our most impressive lineup ever, it’s the gathering that helps you figure out which bets to place when traditional guideposts have disappeared.
Save 15% when you buy a group pass — you can choose your attendees later
- Virtual passes are available at no charge
Can't make it to SF?
Choose a virtual pass.
WHAT TO EXPECT AT ENDPOINTS AT JPM26?
Real people, real conversations, real answers — get the full story from leaders on where we go from here.
Candid discussions about what actually works when funding plateaus and barriers keep rising.
The Endpoints Hub, a coworking space that offers sanctuary to meet, focus, and connect in the midst of the JPM frenzy.
EVENT SPONSORS
